29
October 2024
Target Healthcare REIT plc
and its subsidiaries
("Target Healthcare" or "the
Group")
Net Asset Value, update on
corporate activity and dividend declaration
Target Healthcare (LSE: THRL), the
UK listed specialist investor in modern, purpose-built care homes,
announces its unaudited quarterly Net Asset Value ('NAV') as at 30
September 2024, an update on corporate activity and its first
interim dividend for the year ending 30 June 2025.
Corporate activity highlights
Focus on quality real estate reflected in growing dividend and
sustained EPRA NTA growth, underpinned by structural demographic
tailwinds:
· EPRA
Net Tangible Assets ('NTA') per share increased 0.9% to 111.7 pence
(30 June 2024: 110.7 pence), reflecting a like-for-like valuation
uplift driven by the portfolio's inflation-linked rent
reviews
· EPRA
"topped-up" net initial yield stable at 6.20% (30 June 2024: 6.20%)
based on an annualised contractual rent of
£59.2 million
·
Adjusted EPRA EPS for the
quarter of 1.55 pence per share, fully covering the dividend of
1.471 pence per share which is to be paid in respect of the
quarter
· NAV
total return of 2.2% for the quarter (based on EPRA NTA and
including dividend payment)
· Net
LTV of 22.8% (30 June 2024: 22.5%)
·
Weighted average debt term of 5.0
years (30 June 2024: 5.2 years). Interest costs hedged on 93% of
drawn debt to the relevant facility maturity date with a weighted
average cost of drawn debt of 3.96% (inclusive of amortisation of
arrangement costs)
·
Total capital available of £85
million as at 30 September 2024, net of the Group's capital
commitments including two development assets
· ESG
credentials supported by an improved GRESB score of 71, placing the
Group second in its peer group
Sector-appropriate business model delivering consistent
performance: Diversified tenant base; highly engaged management;
modern real estate with strong environmental credentials.
Underlying portfolio trading continues to support long-term returns
with 1.9x last twelve months rent cover:
· Diversified portfolio of 94 assets let to 34 tenants and
valued at £916.4 million (30 June 2024: £908.5 million) reflecting
an increase of 0.9%. Like-for-like valuation increased by 0.6%,
primarily driven by continued rental growth
· Like-for-like contracted rent increased 0.6%, driven by
inflation-linked upwards-only annual rent reviews
· WAULT
of 26.2 years (30 June 2024: 26.4 years)
· High
quality, modern and sustainable real estate portfolio:
o 99%
of the portfolio is A or B EPC rated, (100%
A to C ratings) and therefore compliant with the minimum energy
efficiency standards anticipated to apply from 2030
o Positive social impact from sector-leading real estate
standards: 99% en suite wet-rooms; generous 48 sqm space per
resident; sustainable rent of £196 per sqm
· Rent
cover on mature homes was stable, at 2.0x
for the June 2024 quarter (most recent quarter of tenant
data)
Kenneth MacKenzie, CEO of Target Fund Managers,
commented:
"The Manager is deeply involved with
care providers, developers and industry bodies and is committed to
a better future for the sector. We recently hosted an event for our
tenants, learning more about their growth aspirations and their
current operational environments, and a round table with key
leaders within the older adult care sector focussed on the role of
the regulator. There was an encouraging consensus on a positive
outlook and the growth opportunity where care is provided well, in
addition to the importance and benefits of quality, whether through
real estate, services, people or regulation.
"With 67% of UK care home beds
unfit-for-purpose in a sector which generates over £20bn per annum
in resident fees, we anticipate no deceleration in the pace of
change of real estate standards as residents and their families
become less willing to accept places without fully private personal
hygiene space, adequate social & outdoor space, and with
sub-standard environmental certification. Our strategy of holding
exclusively modern, purpose-built real estate positions us firmly
on the right side of the increasing sector bifurcation, with a
best-in-class platform that will enable us to grow the portfolio in
a disciplined manner, and deliver compelling investment
returns."
EPRA NTA
The Group's unaudited EPRA NTA per
share as at 30 September 2024 was 111.7 pence and NAV total return
for the quarter was 2.2%.
A balance sheet summary and an
analysis of the movement in the EPRA NTA over the quarter is shown
in the Appendix of this announcement.
Corporate Update
Portfolio performance
As at 30 September 2024, the Group's
portfolio was valued at £916.4 million and comprised 94 properties,
consisting of 92 operational care homes and two pre-let sites,
which are being developed through capped forward funding
commitments with established development partners.
The portfolio value increased by
0.9% over the quarter, comprising:
· a 0.6%
like-for-like increase in the operational portfolio, predominantly
from inflation-linked rent reviews; and
· a 0.3%
increase from capital expenditure, primarily associated with the
two development properties
Contractual rental income increased
by 0.7% over the quarter, comprising:
· a 0.6%
like-for-like increase from 18 inflation-linked upwards-only rent
reviews, with an average uplift of 3.0%; and
· a 0.1%
increase from the rentalisation of capital expenditure incurred,
including the installation of photovoltaic ("PV") panels
The EPRA "topped-up" net initial
yield was 6.20% based on an annualised contractual rent of
£59.2 million and the EPRA net initial yield was 6.15% with
one asset in a rent-free period.
Portfolio update
During the quarter, the following
asset management initiatives were undertaken:
· The
Group facilitated the installation of PV panels at four homes, with
the capital expenditure funded by the Group and rentalised at a
yield ahead of the portfolio EPRA topped-up NIY.
·
Following the completion of the
refurbishment of one of the Group's homes in the North West,
capital expenditure of £0.4 million was similarly
rentalised.
· The
conversion of the final four rooms to provide full en suite
wet-room facilities at one of the Group's homes in North Yorkshire
completed as part of ongoing asset enhancements, increasing the
portfolio towards 100% en suite wet-rooms.
GRESB score
The Group has continued its
participation in the benchmark, receiving an improved score of 71
for the year to December 2023, compared to a peer group average of
65. This placed the Group second amongst its peer group and seventh
in the "Healthcare-listed" segment.
GRESB (Global Real Estate
Sustainability Benchmark) is an independent real estate benchmark
that assesses the sustainability policy of real estate
companies.
Debt
facilities and swap arrangements
As at 30 September 2024, the Group's
total borrowings were £248 million, representing a net LTV of 22.8%
(total gross debt less cash, as a proportion of gross property
value). The Group's weighted average cost on its drawn debt,
inclusive of amortisation of loan arrangement costs, was 3.96% (30
June 2024: 3.91%).
93% of drawn debt is fully
hedged:
· £150 million is fixed with a weighted average term of 9.4
years and a weighted average interest rate of 3.18% (excluding the
amortisation of arrangement fees)
· £30
million of the Group's bank facilities is fixed at 2.48% for 1.1
years through an interest rate swap
· £50
million of the Group's drawn revolving credit facilities have
interest rates capped at 5.17% via a 3% SONIA cap for 1.1
years
· The
remaining £18 million of the Group's drawn revolving credit
facilities carries a variable interest rate of SONIA plus a margin
of 2.18%
The Group has access to a further
£72 million of committed, but undrawn, revolving credit facilities
which, if drawn, would carry an interest rate of SONIA plus 2.21%.
During the quarter, the Group drew down £5 million to fund
construction of the Group's development assets, with £7 million of
such commitments remaining on a cash basis. The Group has also
retained £23 million from recent property disposals as cash in the
short term which it intends to use to reduce its variable rate debt
further and to fund the completion of the two remaining development
assets.
As at 30 September 2024,
the weighted average term to expiry on the Group's total
committed loan facilities was 5.0 years (30 June 2024: 5.2
years) with the earliest maturity in November 2025. In relation to
the Group's shortest dated debt facilities, indicative refinance
terms have been obtained from a number of lenders for a range of
facility types and durations. The Group is pleased with the
potential lender appetite and is carefully evaluating the available
options.
Dividends
The Group paid its fourth interim
dividend for the year ending 30 June 2024, in respect of the period
from 1 April 2024 to 30 June 2024, of 1.428 pence per share,
on 30 August 2024 to shareholders on the register on 16 August
2024. This distribution was comprised wholly of a property income
distribution (PID).
Announcement of first interim dividend
The Company today declares its first
interim dividend for the year ending 30 June 2025, in respect of
the period from 1 July 2024 to 30 September 2024, of 1.471 pence
per share as detailed in the schedule below:
Interim Property Income Distribution
(PID): 1.471 pence per share
Interim ordinary
dividend:
nil
Ex-Dividend Date:
|
14 November 2024
|
Record Date:
|
15 November 2024
|
Payment Date:
|
29 November 2024
|
The quarterly dividend reflects an
annualised dividend of 5.884 pence per share and a dividend yield
of 6.6% based on the 28 October 2024 closing share price of 89.8
pence.
The Company had 620,237,346 ordinary
shares in issue at 30 September 2024 and has not issued or bought
back any shares since that date.
Shareholders entitled to elect to
receive distributions without deduction for withholding tax may
complete the declaration form which is available on request from
the Company through the contact details provided on its
website www.targethealthcarereit.co.uk,
or from the Company's registrar. Shareholders who qualify for gross
payments are, principally, UK resident companies, certain UK public
bodies, UK charities, UK pension schemes and the managers of ISAs,
PEPs and Child Trust Funds, in each case subject to certain
conditions. Individuals and non-UK residents do not qualify for
gross payments of distributions and should not complete the
declaration form.
LEI:
213800RXPY9WULUSBC04
ENDS
Enquiries:
Target Fund Managers Limited
|
Tel: 01786 845 912
|
Kenneth MacKenzie
|
|
Gordon Bland
|
|
|
|
Stifel Nicolaus Europe Limited
|
Tel: 020 7710 7600
|
Mark Young
|
|
Rajpal Padam
|
|
Catriona Neville
|
|
|
|
FTI
Consulting
|
Tel: 020 3727 1000
|
Dido Laurimore
|
TargetHealthcare@fticonsulting.com
|
Richard Gotla
|
|
Notes to editors:
UK listed Target Healthcare REIT plc
(THRL) is an externally managed Real Estate Investment Trust which
provides shareholders with an attractive level of income, together
with the potential for capital and income growth, from investing in
a diversified portfolio of modern, purpose-built care
homes.
The Group's portfolio at 30
September 2024 comprised 94 assets let to 34 tenants with a total
value of £916.4 million.
The Group invests in modern,
purpose-built care homes that are let to high quality tenants who
demonstrate strong operational capabilities and a strong care
ethos. The Group builds collaborative, supportive relationships
with each of its tenants as it believes working in this way helps
raise standards of care and helps its tenants build sustainable
businesses. In turn, that helps the Group deliver stable returns to
its investors.
Important information
The information contained within
this announcement is deemed by the Company to constitute inside
information as stipulated under the UK version of the Market Abuse
Regulations (EU) No. 596/2014, which is part of UK law by virtue of
the European Union (Withdrawal) Act 2018, as amended. Upon the
publication of this announcement via Regulatory Information
Service, this inside information is now considered to be in the
public domain.
APPENDIX
1. Analysis of movement in EPRA
NTA
The following table provides an
analysis of the movement in the unaudited EPRA NTA per share for
the period from 1 July 2024 to 30 September 2024:
|
Pence per
share
|
|
EPRA
NTA per share as at 30 June 2024
|
110.7
|
|
|
|
|
Revaluation gains / (losses) on
investment properties
|
0.8
|
|
Revaluation gains / (losses) on
assets under construction^
|
0.1
|
|
Movement in revenue
reserve
|
1.5
|
|
Fourth interim dividend payment for
the year ended 30 June 2024
|
(1.4)
|
|
EPRA
NTA per share as at 30 September 2024
|
111.7
|
|
Percentage change in the quarter
|
0.9%
|
|
The EPRA Best Practices
Recommendations Guidelines state that companies should publish a
set of three NAV metrics. The full set of EPRA NAV metrics are
published in the Group's Annual Report. The Company intends to
continue to announce the EPRA NTA on a quarterly basis.
At 30 September 2024, due to the
valuation ascribed to the Group's interest rate derivative
contracts used to hedge its exposure to variable interest rates,
which are excluded from the calculation of the EPRA NTA, the
unaudited NAV calculated under International Financial Reporting
Standards was 112.0 pence per share.
^Consistent with standard valuation
practice for assets under construction, the carrying value of these
assets is calculated by the valuer through application of a
discount to accumulated costs to date. This discount varies
depending on factors such as the remaining development time. As the
asset progresses towards completion, the discount that has been
applied is unwound.
2. Summary balance sheet
(unaudited)
|
|
|
Sept-24
|
Jun-24
|
Mar-24
|
Dec-23
|
|
£m
|
£m
|
£m
|
£m
|
Property portfolio*
|
916.4
|
908.5
|
934.8
|
911.1
|
Cash
|
38.9
|
38.9
|
17.9
|
17.6
|
Net current assets /
(liabilities)*
|
(14.6)
|
(17.9)
|
(17.3)
|
(14.7)
|
Loans
|
(248.0)
|
(243.0)
|
(259.0)
|
(252.5)
|
Net
assets
|
692.7
|
686.5
|
676.4
|
661.5
|
|
|
|
|
|
EPRA NTA per share (pence)
|
111.7
|
110.7
|
109.0
|
106.7
|
*Properties within the portfolio are
stated at the market value provided by the external valuer and the
IFRS effects of fixed/guaranteed minimum rent reviews are not
reflected.
3. External
Valuer
The valuation of the property
portfolio as at 30 September 2024 was conducted by CBRE
Limited.
The next quarterly valuation of the
property portfolio will be conducted by CBRE Limited during January
2025 and the unaudited EPRA NTA per share as at 31 December 2024 is
expected to be announced thereafter.
4. EPRA NIY profiles and unwind of
rent-free period
The Group currently has one asset
with a rent-free period. As this unwinds, assuming no other changes
including inter alia the portfolio valuation or rental profile, the
EPRA yield profiles for the portfolio will be as
follows:
|
|
|
30 September
2024
|
31 December
2024
|
EPRA "topped-up" NIY
|
|
|
6.20%
|
6.20%
|
EPRA NIY
|
|
|
6.15%
|
6.20%
|
Contractual rent (£m)
|
|
|
59.2
|
59.2
|
Passing rent (£m)
|
|
|
58.7
|
59.2
|